文献速递呼吸衰竭与机械通气重症综合管理与镇静镇痛

重组ACE2蛋白可减轻SARS-CoV-2刺突RBD蛋白诱导的急性肺损伤

Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein.
PubMed 文献 · Crit Care · 2022-06-09
一句话结论动物实验显示,重组ACE2蛋白通过结合SARS-CoV-2刺突RBD蛋白并裂解AngI或AngII,逆转RBD加重的LPS诱导急性肺损伤。

本研究在小鼠模型中证实,SARS-CoV-2刺突受体结合域(RBD)蛋白可加重脂多糖(LPS)诱导的急性肺损伤。机制上,RBD蛋白直接结合并下调ACE2,导致AngII升高,AngII通过AT1R上调NOX1/2,引起氧化应激和失控性炎症,最终导致ALI/ARDS。重组ACE2蛋白(rACE2)通过直接结合RBD蛋白、裂解AngI或裂解AngII,显著逆转RBD蛋白诱导的急性肺损伤。该研究首次在动物模型中证明rACE2对SARS-CoV-2刺突RBD蛋白加重的LPS诱导ALI具有保护作用,并阐明ACE2-AngII-AT1R-NOX1/2轴可能参与SARS-CoV-2诱导的ALI。

要点

  • SARS-CoV-2刺突RBD蛋白可加重小鼠LPS诱导的急性肺损伤。
  • RBD蛋白直接结合并下调ACE2,升高AngII,经AT1R上调NOX1/2,导致氧化应激和失控性炎症。
  • 重组ACE2蛋白通过直接结合RBD蛋白、裂解AngI或AngII,显著逆转RBD蛋白诱导的急性肺损伤。
  • ACE2-AngII-AT1R-NOX1/2轴可能参与SARS-CoV-2诱导的急性肺损伤。

适用人群与场景

  • 小鼠模型:SARS-CoV-2刺突RBD蛋白加重的LPS诱导急性肺损伤模型。

研究设计与关键结果

  • 研究类型:动物实验(小鼠模型)。
  • SARS-CoV-2刺突RBD蛋白加重LPS诱导的小鼠急性肺损伤。
  • 机制:RBD蛋白直接结合并下调ACE2,导致AngII升高;AngII通过AT1R上调NOX1/2,引起氧化应激和失控性炎症,最终导致ALI/ARDS。
  • 重组ACE2蛋白通过直接结合SARS-CoV-2刺突RBD蛋白、裂解AngI或裂解AngII,显著逆转RBD蛋白诱导的急性肺损伤。

证据类型、等级与局限

  • 证据类型:动物实验。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 原文未据此给出推荐。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: SARS-CoV-2 infection leads to acute lung injury (ALI) and acute respiratory distress syndrome (ARDS). Both clinical data and animal experiments suggest that the renin-angiotensin system (RAS) is involved in the pathogenesis of SARS-CoV-2-induced ALI. Angiotensin-converting enzyme 2 (ACE2) is the functional receptor for SARS-CoV-2 and a crucial negative regulator of RAS. Recombinant ACE2 protein (rACE2) has been demonstrated to play protective role against SARS-CoV and avian influenza-induced ALI, and more relevant, rACE2 inhibits SARS-CoV-2 proliferation in vitro. However, whether rACE2 protects against SARS-CoV-2-induced ALI in animal models and the underlying mechanisms have yet to be elucidated.

METHODS AND RESULTS: Here, we demonstrated that the SARS-CoV-2 spike receptor-binding domain (RBD) protein aggravated lipopolysaccharide (LPS)-induced ALI in mice. SARS-CoV-2 spike RBD protein directly binds and downregulated ACE2, leading to an elevation in angiotensin (Ang) II. AngII further increased the NOX1/2 through AT1R, subsequently causing oxidative stress and uncontrolled inflammation and eventually resulting in ALI/ARDS. Importantly, rACE2 remarkably reversed SARS-CoV-2 spike RBD protein-induced ALI by directly binding SARS-CoV-2 spike RBD protein, cleaving AngI or cleaving AngII.

CONCLUSION: This study is the first to prove that rACE2 plays a protective role against SARS-CoV-2 spike RBD protein-aggravated LPS-induced ALI in an animal model and illustrate the mechanism by which the ACE2-AngII-AT1R-NOX1/2 axis might contribute to SARS-CoV-2-induced ALI.

来源:Crit Care,查看原文。版权归原作者所有。

参考来源

  1. Zhang L, Zhang Y, Qin X, et al. Recombinant ACE2 protein protects against acute lung injury induced by SARS-CoV-2 spike RBD protein. Crit Care. 2022. PMID: 35681221. doi:10.1186/s13054-022-04034-9

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。